Content deleted Content added
CrimelordCanada (talk | contribs) Removed the legal status listing for Canada which identified it as Schedule I. Although 3C-P might be considered an amphetamine analogue 3C-P is not listed on any of the CDSA schedules explicitly under any name. Tags: Mobile edit Mobile web edit |
Gettinglit (talk | contribs) |
||
(5 intermediate revisions by 3 users not shown) | |||
Line 32: | Line 32: | ||
}} |
}} |
||
'''3C-P''' is a [[psychedelic drug|psychedelic]] [[phenethylamine]]. It has structural and pharmacodynamic properties similar to the drugs [[mescaline]], [[proscaline]], and [[amphetamine]]. Little information exists on the human [[pharmacology]] of 3C-P, but a psychedelic dosage appears to be 20–40 mg,{{medcn|date=February 2018}} and is accompanied by [[stimulant]] and [[Psychedelic experience|psychedelic]] effects such as visual enhancement and distortion.{{medcn|date=February 2018}} It can be synthesized from [[syringaldehyde]] by reaction with [[n-Propyl iodide|''n''-propyl iodide]] followed by condensation with nitroethane and reduction.<ref>{{cite journal| vauthors = Trachsel D |title=Synthese von neuen (Phenylalkyl)aminen zur Untersuchung von Struktur-Aktivitätsbeziehungen, Mitteilung 1, Mescalin Derivate|journal=Helvetica Chimica Acta|date=September 2002|volume=85|issue=9|pages=3019–3026|doi=10.1002/1522-2675(200209)85:9<3019::AID-HLCA3019>3.0.CO;2-4}}</ref> |
'''3C-P''' ('''α-Methyl-4-propoxy-3,5-dimethoxyphenethylamine''') is a [[psychedelic drug|psychedelic]] [[phenethylamine]]. It has structural and pharmacodynamic properties similar to the drugs [[mescaline]], [[proscaline]], and [[amphetamine]]. Little information exists on the human [[pharmacology]] of 3C-P, but a psychedelic dosage appears to be 20–40 mg,{{medcn|date=February 2018}} and is accompanied by [[stimulant]] and [[Psychedelic experience|psychedelic]] effects such as visual enhancement and distortion.{{medcn|date=February 2018}} It can be synthesized from [[syringaldehyde]] by reaction with [[n-Propyl iodide|''n''-propyl iodide]] followed by condensation with nitroethane and reduction.<ref>{{cite journal| vauthors = Trachsel D |title=Synthese von neuen (Phenylalkyl)aminen zur Untersuchung von Struktur-Aktivitätsbeziehungen, Mitteilung 1, Mescalin Derivate|journal=Helvetica Chimica Acta|date=September 2002|volume=85|issue=9|pages=3019–3026|doi=10.1002/1522-2675(200209)85:9<3019::AID-HLCA3019>3.0.CO;2-4}}</ref> |
||
==See also== |
==See also== |
||
*[[Phenethylamine]] |
*[[Phenethylamine]] |
||
*[[3C-AL]] |
|||
*[[3C-MAL]] |
|||
==References== |
==References== |
Latest revision as of 02:18, 27 June 2023
Legal status | |
---|---|
Legal status | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C14H23NO3 |
Molar mass | 253.342 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
3C-P (α-Methyl-4-propoxy-3,5-dimethoxyphenethylamine) is a psychedelic phenethylamine. It has structural and pharmacodynamic properties similar to the drugs mescaline, proscaline, and amphetamine. Little information exists on the human pharmacology of 3C-P, but a psychedelic dosage appears to be 20–40 mg,[medical citation needed] and is accompanied by stimulant and psychedelic effects such as visual enhancement and distortion.[medical citation needed] It can be synthesized from syringaldehyde by reaction with n-propyl iodide followed by condensation with nitroethane and reduction.[1]
See also
References
- ^ Trachsel D (September 2002). "Synthese von neuen (Phenylalkyl)aminen zur Untersuchung von Struktur-Aktivitätsbeziehungen, Mitteilung 1, Mescalin Derivate". Helvetica Chimica Acta. 85 (9): 3019–3026. doi:10.1002/1522-2675(200209)85:9<3019::AID-HLCA3019>3.0.CO;2-4.
External links